Gyomor- és nyelőcsőrák: vizsgálatok itt: Kína
724 trials · From ClinicalTrials.gov, checked 2026. november 19.. Ask the study team whether a trial fits you.
- 1/2. fázisTaking peopleImmunotherapy in Combination With Chemoradiotherapy in Unresectable Locally Advanced Esophageal Cancer
- Where
- Shanghai
- Életkor
- 18 év to 75 év
- People
- 50
- Run by
- Shanghai Chest Hospital
See details and how to joinNCT06173986 - 2. fázisTaking peoplePerioperative Disitamab Vedotin Plus Toripalimab and XELOX in Gastric or Gastroesophageal Junction Adenocarcinoma.
- Where
- Beijing, Chengdu, Fuzhou, Guangzhou, Harbin, Jinan, Kunming, Wuwei, Xiamen, Zhengzhou
- Életkor
- 18 év and over
- People
- 90
- Run by
- RemeGen Co., Ltd.
See details and how to joinNCT06155383 - No phaseTaking peopleA Study of PD-1 Inhibitors Combined With Fruquintinib and Chemotherapy in First-line Treatment of HER2-negative Advanced G/GEJ Cancer
- Where
- Shanghai
- Életkor
- 18 év to 80 év
- People
- 58
- Run by
- Fudan University
See details and how to joinNCT06158919 - 2. fázisNot yet taking people in KínaA Perioperative Sintilimab and Chemotherapy in Esophageal Squamous Cell Carcinoma
- Where
- Shanghai
- Életkor
- 18 év to 75 év
- People
- 182
- Run by
- Fudan University
See details and how to joinNCT06152978 - 2. fázisTaking peopleXELOX Combined With Fruquintinib and Sintilimab Regimen Conversion Therapy for Gastric Cancer/Gastroesophageal Junction Adenocarcinoma Only With Liver and/or Retroperitoneal Lymph Node Metastasis, a Prospective Single-arm, Multicenter Study
- Where
- Nanjin
- Életkor
- 18 év to 75 év
- People
- 43
- Run by
- Xiaofeng Chen
See details and how to joinNCT06091423 - No phaseTaking peopleMRI and CT Simulation in the Evaluation of Tumor Response and Target Volume Definition for Esophageal or Esophagogastric Cancer Patients Undergoing Chemoradiotherapy
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 300
- Run by
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
See details and how to joinNCT02988921 - 2. fázisTaking peopleCadonilimab Combination With Chemotherapy With or Without AK117 in Resectable Gastric or Gastroesophageal Junction Adenocarcinoma
- Where
- Tianjin
- Életkor
- 18 év to 75 év
- People
- 90
- Run by
- Akeso
See details and how to joinNCT05960955 - 1. fázisTaking peopleClinical Study of CEA Targeting Chimeric Antigen Receptor T Lymphocytes(CAR-T) for CEA Positive Advanced Malignant Solid Tumors
- Where
- Wuhu
- Életkor
- 18 év and over
- People
- 60
- Run by
- Chongqing Precision Biotech Co., Ltd
See details and how to joinNCT06126406 - 2. fázisTaking peopleRadiotherapy + Chemoimmunotherapy Followed by Surgery in Patients With Limited Metastatic Gastric or GEJ Cancer
- Where
- Shanghai
- Életkor
- 18 év to 75 év
- People
- 55
- Run by
- Fudan University
See details and how to joinNCT06121700 - 2. fázisTaking peopleXELOX Combined With Anlotinib and Penpulimab vs XELOX as Adjuvant Therapy in ctDNA Positive Gastric and Esophagogastric Junction Adenocarcinoma
- Where
- Nanjing
- Életkor
- 18 év to 75 év
- People
- 80
- Run by
- The First Affiliated Hospital with Nanjing Medical University
See details and how to joinNCT05494060 - 2. fázisTaking peopleCamrelizumab Combined With Chemoradiotherapy in Advanced Esophageal Cancer.
- Where
- Fuzhou
- Életkor
- 18 év to 75 év
- People
- 75
- Run by
- Fujian Cancer Hospital
See details and how to joinNCT05624099 - 2. fázisTaking peopleNeoadjuvant Therapy With Nab-paclitaxel and Cisplatin for Locally Advanced Esophageal Squamous Cell Carcinoma
- Where
- Shijiazhuang
- Életkor
- 18 év to 75 év
- People
- 202
- Run by
- Hebei Medical University Fourth Hospital
See details and how to joinNCT03964753 - No phaseTaking peopleAI Prediction of Gastric Cancer Response to Neoadjuvant Chemotherapy
- Where
- Beijing, Changsha, Fuzhou, Guangzhou, Kunming, Nanning, Qingdao, Shanghai, Shenyang, Suzhou, Tianjin, Zhengzhou, Zhenjiang
- Életkor
- 18 év and over
- People
- 200 worldwide
- Run by
- Chinese Academy of Sciences
See details and how to joinNCT06035250 - 2. fázisTaking peoplePerioperative Tislelizumab Plus Chemotherapy for Resectable Thoracic Oesophageal Squamous Cell Carcinoma
- Where
- Shanghai
- Életkor
- 18 év to 75 év
- People
- 73
- Run by
- Guo Xufeng
See details and how to joinNCT06056336 - No phaseTaking peopleA Multicenter, RCT Study of the Clinical Efficacy of Robotic and Laparoscopic Gastrectomy in Neoadjuvant Gastric Cancer
- Where
- Qingdao
- Életkor
- 18 év to 75 év
- People
- 588
- Run by
- The Affiliated Hospital of Qingdao University
See details and how to joinNCT06042998 - 1. fázisTaking peopleA Clinical Trial Targeting CEA Chimeric Antigen Receptor T (CAR-T) for CEA Positive Advanced Malignant Solid Tumors
- Where
- Hangzhou
- Életkor
- 18 év and over
- People
- 30
- Run by
- Chongqing Precision Biotech Co., Ltd
See details and how to joinNCT06043466 - No phaseCsak meghívásosCarrelizumab Combined With Concurrent Radiotherapy and Chemotherapy for Unresectable Esophageal Squamous Cell Carcinoma
- Where
- Nanjing
- Életkor
- 18 év to 75 év
- People
- 30
- Run by
- The First Affiliated Hospital with Nanjing Medical University
See details and how to joinNCT06048926 - No phaseTaking peopleThe Role of Extracellular DNA (ecDNA) in the Occurrence and Development of Gastric
- Where
- Xi'an
- Életkor
- 18 év to 80 év
- People
- 1000
- Run by
- Xijing Hospital
See details and how to joinNCT05956847 - No phaseNot yet taking people in KínaRAE Versus MIE in Patients With Esophageal Cancer After Neoadjuvant Therapy
- Where
- Shanghai
- Életkor
- 18 év to 75 év
- People
- 300
- Run by
- Shanghai Chest Hospital
See details and how to joinNCT06012214 - 2. fázisTaking peopleNeoadjuvant Therapy for Stage II-IVA Resectable Esophageal Squamous Cell
- Where
- Xi'an, Xi’an
- Életkor
- 18 év to 75 év
- People
- 114
- Run by
- Tang-Du Hospital
See details and how to joinNCT06006650 - 1. fázisTaking peopleAdjuvant Chemotherapy in Combination With Tislelizumab in Lymph Node-Positive Esophageal Squamous Cell Carcinoma
- Where
- Shantou
- Életkor
- 18 év to 70 év
- People
- 50
- Run by
- Affiliated Cancer Hospital of Shantou University Medical College
See details and how to joinNCT05984342 - 2. fázisNot yet taking people in KínaPerioperative Chemotherapy Plus Toripalimab for Epstein-Barr Virus-associated Locally Advanced Gastric or Esophagogastric Junction Adenocarcinoma
- Where
- Hangzhou, Huzhou, Lishui, Ningbo, Taizhou
- Életkor
- 18 év to 80 év
- People
- 30
- Run by
- Yu jiren
See details and how to joinNCT05970627 - 2. fázisTaking peoplePerioperative Chemotherapy Plus Toripalimab for dMMR Locally Advanced Gastric or Esophagogastric Junction Adenocarcinoma
- Where
- Hangzhou, Huzhou, Lishui, Ningbo, Taizhou
- Életkor
- 18 év to 80 év
- People
- 90
- Run by
- Yu jiren
See details and how to joinNCT05729646 - No phaseTaking peopleMinimally Residual of Esophageal Cancer 001
- Where
- Shijiazhuang
- Életkor
- 18 év to 75 év
- People
- 56
- Run by
- Hebei Medical University Fourth Hospital
See details and how to joinNCT05952661 - No phaseTaking peopleValue of Pleural Lavage Cytology in Resectable Esophageal Carcinoma Eastern Cooperative Thoracic Oncology Projects 2005, ECTOP-2005)
- Where
- Hefei, Nantong, Shanghai, Shijiazhuang, Taishing, Taizhou, Tianjin, Xi'an, Xi’an, Zhengzhou
- People
- 385
- Run by
- Fudan University
See details and how to joinNCT05443841